RELISTOR 12 mg/0,6 ml, solution injectable

Business Listing - September 04, 2021

RELISTOR 12 mg/0,6 ml, solution injectable

RELISTOR 12 mg/0,6 ml, solution injectable solution injectable sous-cutanée Autorisation active Procédure centralisée Commercialisée 7/2/2008 BAUSCH HEALTH IRELAND (IRLANDE)

Tags & Categories

active solution injectable autorisation procédure commercialisée cutanée centralisée relistor bausch

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business